			Home About us Contact

Glycol Alginate (glycol + alginate)

Distribution by Scientific Domains

Medical Sciences	80%

Kinds of Glycol Alginate

propylene glycol alginate

Selected Abstracts

Enamel matrix derivative and titanium implants

JOURNAL OF CLINICAL PERIODONTOLOGY, Issue 4 2003
An experimental pilot study in the rabbit
Aim: The aim of present study was to evaluate if an enamel matrix derivative (Emdogain®) may enhance bone formation and osseointegration of titanium implants, using a well-documented rabbit model. Material and methods: Thirty-six threaded commercially pure titanium (cp.ti.) implants were inserted in six New Zealand white rabbits. One implant was placed in each femur and two in each tibia. Prior to implant insertion approximately 0.5 mL of Emdogain (EMD) (test) or the vehicle gel (PGA: propylene glycol alginate) (control) was injected into the surgically prepared implant site. The follow-up time was 6 weeks. Biomechanical evaluations by resonance frequency analysis (RFA) and removal torque measurements (RTQ) were performed. Histomorphometrical quantifications were made on ground sections by measurements of the percentage of bone-to-metal contact, bone area inside the threads as well as outside the threads (mirror image). Bone lengths along the implant surface were also measured and used for shear strength calculations. Results: The results demonstrated no beneficial effects from the EMD treatment on bone formation around titanium implants in any of the tested parameters. Significant differences were demonstrated with removal torque test and shear force calculations for the control implants. No other parameter demonstrated a statistically significant difference. Conclusion: The results of the present study may indicate that EMD does not contribute to bone formation around titanium implants. This observation may indicate that the bone formation that occurs after EMD treatment in periodontal defects is the result of functional adaptation. However, further research is required to evaluate the effect of EMD treatment on bone formation. Zusammenfassung Schmelzmatrixprotein und Titanimplantate. Eine experimentelle Pilotstudie beim Kaninchen Zielsetzung: Untersuchung im gut dokumentierten Kaninchenmodell, ob Schmelzmatrixprotein (Emdogain®) die Knochenbildung und Osseointegration von Titanimplantaten verbessert. Material und Methoden: 36 kommerziell erhältliche Schraubenimplantate aus reinem Titan (cp.ti.) wurden bei 6 weißen Neuseeländischen Kaninchen inseriert. Ein Implantat wurde in jeden Femur und 2 in jede Tibia gesetzt. Vor Implantatinsertion wurden etwa 0,5 ml Emdogain (EMD) (Test) oder das Trägergel (PGA: Propylenglykolalginat) (Kontrolle) in die chirurgisch vorbereitete Insertionsstelle gespritzt. Die Nachuntersuchungszeit betrug 6 Wochen. Die biomechanischen Untersuchungen umfassten eine Resonanzfrequenzanalyse (RFA) und die Messung des Drehmoments, das zur Entfernung der Implantate nötig war (RTQ). Folgende histomorphometrische Messungen wurden auf Schliffpräparaten durchgeführt: Messung des prozentualen Knochen-zu-Metall-Kontaktes, Knochenbereich innerhalb und außerhalb der Schraubengewinde (Spiegelbild). Die Knochenlänge entlang der Implantate wurde ausgemessen und für Scherkraftberechnungen genutzt. Ergebnisse: Es konnten für keinen der untersuchten Parameter günstige Auswirkungen der Anwendung von EMD auf die Knochenbildung um Titanimplantate beobachtet werden. Signifikante Unterschiede konnten für RTQ und Scherkraftberechnungen für die Kontrollimplantate gezeigt werden. Für keinen anderen Parameter konnten statistisch signifikante Unterschiede gefunden werden. Schlussfolgerungen: Die Ergebnisse dieser Studie zeigen, dass der Einsatz von EMD nicht zur Knochenbildung um Titanimplantate beiträgt. Diese Beobachtung kann darauf hinweisen, dass die Knochenbildung, die nach Gabe von EMD in parodontalen Defekten stattfindet, das Ergebnis funktioneller Adaptation ist. Allerdings sind weitere Untersuchungen erforderlich, um die Auswirkung von EMD auf die Knochenbildung zu verstehen. Résumé Dérivés de la matrice amellaire et implants en titane. Une étude pilote expérimentale sur le lapin. But: Le but de cette étude était d'évaluer si un dérivé de la matrice amellaire (Emdogain®) pouvait augmenter la formation osseuse et l'ostéo-intégration d'implants en titane en utilisant un modèle éprouvé de lapin. Matériel et méthodes: 36 implants en titane commercialement purs (cp.ti.) ont été vissés chez 6 lapins blancs de Nouvelle Zélande. 1 implant fut placé dans chaque fémur et 2 dans chaque tibia. Préalablement à l'insertion, environ 0.5 mL d' Emdogain (EMD) (test) ou du gel vecteur (PGA: propylene glycol alginate) (control) fut injecté dans le site implantaire préparé chirurgicalement. Le suivi était réalisé sur 6 semaines. Des évaluations biomécaniques par analyse de la fréquence de résonance (RFA) et des mesures de torque de retrait (RTQ) furent utilisées. Les quantifications histo-morphométriques furent réalisées sur des coupes en mesurant le pourcentage de contact os-métal, les surfaces osseuses à l'intérieur ainsi qu'à l'extérieur des spires (Image miroir). Les longueurs d'os le long des surfaces implantaires furent aussi mesurées et utilisées pour calculer les forces de cisaillement. Résultats: Les résultats n'ont montré aucun effet bénéfique du traitement à l'EMD sur la formation osseuse autour des implants en titane pour aucun des paramètres test. De significatives différences furent trouvées avec le test de torque et les calculs de force de cisaillement pour les implants contrôles. Aucun autre paramètre ne montrait de différences statistiquement significatives. Conclusion: Les résultats de cette étude pourrait indiquer que l'EMD ne contribue pas à la formation osseuse autour des implants en titane. Cette observation peut indiquer que la formation osseuse qui survient après traitement à l'EMD dans les lésions parodontales serait le résultat d'une adaptation fonctionnelle. Cependant, de futures recherches sont nécessaires pour évaluer l'effet du traitement à l'EMD sur la formation osseuse. [source]

Effect of an enamel matrix protein derivative (Emdogain®) on ex vivo dental plaque vitality

JOURNAL OF CLINICAL PERIODONTOLOGY, Issue 11 2001
Anton Sculean
Abstract Background: A common clinical observation following surgical periodontal therapy with an enamel matrix derivative (Emdogain®) is the improved healing of the soft tissues and the limited inflammation of the operated areas. These clinical observations are empirical and difficult to explain. One of the factors influencing the early wound healing might be a potential antimicrobial effect of Emdogain®. Aim: To investigate the effect of Emdogain® on the vitality of ex vivo supragingival dental plaque and to compare this effect to that of a standard 0.2% chlorhexidine solution. Materials and Methods: 24 patients suffering from adult periodontitis were included in the study. At the beginning of the experiment, all participants were given a professional tooth cleaning. For the following 4 days, they had to refrain from any kind of oral hygiene measures. At day 5, from each of the volunteers, a voluminous plaque biofilm sample was taken with a sterile curette from the vestibular surfaces of the 1st lower molars and divided into 5 equal parts. Each part was mounted with 5 ,l of the following solutions: (1) NaCl, (2) enamel matrix derivative dissolved in water (EMD), (3) enamel matrix derivative dissolved in the vehicle (Emdogain®), (4) vehicle (propylene glycol alginate, PGA), (5) 0.2% chlorhexidine digluconate (CHX). After a reaction time of 2 min the test solutions were sucked off, and subsequently the biofilm was stained with a fluorescence dye. The vitality of the plaque flora after the treatments was evaluated under the fluorescence microscope (VF%). Results: Plaque samples treated with NaCl showed a mean vitality of 76.8±8%. The EMD, Emdogain®, PGA and CHX showed VF values of 54.4±9.2, 21.4±10.6%, 19.6±11.6% and 32.3±11.8%, respectively. Emdogain®, PGA and CHX showed statistically highly significant reductions (p<0.0001) in terms of bacteria vitality when compared to water (negative control) and EMD. Both Emdogain® and PGA were found to be statistically significantly different compared to CHX (p<0.001) (positive control). Conclusion: The results of this study indicate that Emdogain® might have an antibacterial effect on the vitality of the ex vivo supragingival dental plaque flora. Zusammenfassung Hintergrund: Eine allgemeine klinische Beobachtung nach parodontalchirurgischer Therapie mit einem Schmelzmatrixderivat (Emdogain®) ist die verbesserte Heilung des Weichgewebes und die begrenzte Entzündung des operierten Gebietes: Diese klinischen Beobachtungen sind empirisch und schwierig zu erklären. Ein Faktor, der die frühe Wundheilung beeinflusst, könnte ein potentieller antimikrobieller Effekt von Emdogain® sein. Ziel: Untersuchung des Effektes von Emdogain® auf die Vitalität von ex vivo supragingivaler dentaler Plaque und Vergleich dieses Effektes zu demjenigen einer Standard 0.2%igen Chlorhexidinlösung. Material und Methoden: 24 Patienten, die an einer Erwachsenen-Parodontitis litten, wurden in diese Studie aufgenommen. Zu Beginn der Studie wurde bei allen Teilnehmern eine professionelle Zahnreinigung durchgeführt. An den folgenden 4 Tagen wurden keine oralen Hygienemaßnahmen erlaubt. Am Tag 5 wurde von jedem Teilnehmer eine voluminöse Plaquebiofilmprobe mit einer sterilen Kürette von der vestibulären Oberfläche des ersten unteren Molaren genommen und in 5 gleiche Teile aufgeteilt. Jeder Teil wurde mit 5 ,l der folgenden Lösungen gemischt: (1) NaCl, (2) Schmelzmatrixderivat in Wasser gelöst (EMD), (3) Schmelzmatrixderivat in einem Vehikel gelöst (Emdogain®), (4) Vehikel (Propylenglycolalginat, PGA), (5) 0.2%iges Chlorhexidindiglukonat (CHX). Nach einer Reaktionszeit von 2 Minuten wurden die Testlösungen aufgesaugt und folgend der Biofilm mit Fluoreszenzfarbstoff gefärbt. Die Vitalität der Plaqueflora nach den Behandlungen wurde unter dem Vitalfluoreszenzmikroskop (VF%) evaluiert. Ergebnisse: Die Plaqueproben, die mit NaCl behandelt wurden, zeigten eine mittlere Vitalität von 76.8±8%. Das EMD, Emdogain®, PGA und CHX zeigten VF Werte von 54.4±9.2%, 21.4±10.6%, 19.6±11.6% und 32.3±11.8%. Emdogain®, PGA und CHX zeigten statistisch signifikant höhere Reduktionen (p<0.0001) in Beziehung zur bakteriellen Vitalität, wenn zu Wasser (negative Kontrolle) und EMD verglichen wurde. Sowohl Emdogain® und PGA waren statistisch signifikant unterschiedlich zu CHX (p<0.0001) (positive Kontrolle). Schlussfolgerung: Die Ergebnisse dieser Studie zeigten, dass Emdogain® einen antibakteriellen Effekt auf die Vitalität von supragingivaler dentaler ex vivo Plaqueflora haben könnte. Résumé Origine: Une observation clinique courante durant un traitement parodontal chirurgical à l'aide de protéines de la matrice améllaire (Emdogain®) est une meilleure guérison des tissus mous et une inflammation moindre. Ces observations cliniques sont empiriques et difficiles à expliquer. Un des facteurs influençant la guérison précoce peut être un effet antimicrobien de l'EMD. But: Le but de cette étude a été d'évaluer l'effet de l'Emdogain® sur la vitalité de la plaque dentaire sus-gingivale ex vivo et de comparer cet effet avec une solution de chlorhexidine 2%. Matériaux et Méthodes: 24 patients souffrant de parodontite de l'adulte ont été inclus dans cette étude. Au début de l'expérience, tous les participants ont recu un nettoyage dentaire professionnel. Pendant les 4 journées suivantes, ils ont dû arrêté toute hygiène buccale. Au jour 5, une quantité de plaque dentaire volumineuse a étééchantillonné des surfaces vestibulaires des premières molaires inférieures de chaque volontaire à l'aide d'une curette stérile et divisée en 5 parts égales. Chaque partie a été montée avec 5 ,l des solutions suivantes: (1) NaCl, (2) EMD: dérivé de la matrice améllaire dissout dans l'eau (3) Emdogain®: dérivé de la matrice améllaire dissout dans son véhicule, (4) PGA: le véhicule propylène glycol alginate, (5) CHX: chlorhexidine 0.2%. Après un temps de réaction de 2 min, les solutions tests ont été aspirées et le biofilm dentaire a été imprégné d'un colorant de fluorescence. La vitalité de la flore de la plaque dentaire après ces traitements a étéévaluée sous microscopie à fluorescence (VF%). Résultats: Les échantillons de plaque traités avec NaCl possèdaient une vitalité moyenne de 76.8±8%. L'EMD, Emdogain®, PGA, et CHX avaient des valeurs VF respectives de 54.4±9.2%, 21.4±10.6%, 19.6±11.6% et 32.3±11.8%. Emdogain®, PGA, et CHX réduisaient la vitalité bactérienne de manière très hautement significative (p<0.0001) lorsque ces solutions étaient comparées aux contrôle négatif NaCl et à EMD. Tant Emdogain® que PGa étaient différents comparés au contrôle positif CHX (p<0.001). Conclusions: Les résultats de cette étude indiquent que Emdogain® pourrait avoir un effet antibactérien sur la vitalité de la flore se trouvant dant la plaque dentaire sus-gingivale ex vivo. [source]

The role of macrophages in the periodontal regeneration using Emdogain® gel

JOURNAL OF PERIODONTAL RESEARCH, Issue 2 2008
N. Fujishiro
Background and Objective:, Emdogain® gel is clinically used as a periodontal regenerative material. However, the mechanism of the regeneration has not been completely elucidated. Although many studies have focused on the regenerative effect of Emdogain on connective tissue attachment and alveolar bone, the role of macrophages and the expression of growth factors remains unclear in the regeneration stimulated by Emdogain gel in vivo. The aim of this study was to investigate the effect of Emdogain gel on the expression of cytokines and growth factors by macrophages in vivo using a newly devised rat experimental periodontitis model. Material and Methods:, Rat experimental periodontitis was induced by elevating a full-thickness gingival flap and ligating silk threads around the first molars of the mandible. At 14 d after inducing experimental periodontitis, Emdogain gel or propylene glycol alginate was applied to the furcation area. The rats were killed 7 and 14 d after treatment with propylene glycol alginate or Emdogain gel. The expression of cytokines and growth factors, and the regeneration of periodontal tissue, were examined by histochemical and immunohistochemical methods. Results:, Fourteen days after the induction of periodontitis, the resorption of alveolar bone at furcation was observed and cytokines such as interleukin-1,, transforming growth factor-,1, receptor activator of nuclear factor-,B ligand, receptor activator of nuclear factor-,B and osteoprotegerin were found. In the Emdogain-treatment group, the formation of new acellular cementum and, more remarkably, recovery of the bone, were observed. The new bone formation ratio in the Emdogain treatment group was significantly higher than that of the propylene glycol alginate treatment group. Although the expression of cytokines such as interleukin-1,, transforming growth factor-,1, receptor activator of nuclear factor-,B ligand and receptor activator of nuclear factor-,B was very low, bone morphogenetic protein-2- and bone morphogenetic protein-4-expressing macrophages were observed close to the root, and bone morphogenetic protein-4-expressing macrophages were mainly observed close to the bone surface at the furcation in the Emdogain-treatment group. Conclusion:, These results suggest that wound-healing macrophages may express bone morphogenetic protein and play an important role in the regeneration of periodontal tissue at the furcation following the application of Emdogain gel. [source]

IMPROVEMENT OF PHYSICAL PROPERTIES OF NONFAT FERMENTED MILK DRINK BY USING WHEY PROTEIN CONCENTRATE

JOURNAL OF TEXTURE STUDIES, Issue 3 2009
ASLI E. OZEN
ABSTRACT The use of whey protein concentrate (WPC) for the improvement of physical properties of nonfat fermented milk drink was investigated. Drinks were prepared from nonfat milk powder and WPC at different proportions. Rheological properties, serum separation and particle size of the drinks were measured. The effect of WPC on the physical properties of the drinks was evaluated by comparison with those of commonly used stabilizers, including propylene glycol alginate and locust bean gum. WPC addition caused an increase in the consistency coefficient and thixotropy and a decrease in the particle size of the samples. There was no serum separation in the sample with 2% WPC. Large unstable aggregates were observed in the sample with 3% WPC, which also exhibited the highest serum separation. WPC up to a level of 2% positively influenced the physical properties of nonfat fermented milk drink similar to stabilizers. PRACTICAL APPLICATIONS Fermented milk drinks are consumed especially for their beneficial health effects. Physical properties of fermented milk drinks influence their quality and consumer acceptability. Hydrocolloid stabilizers are used for the improvement of physical properties of fermented milk products. Whey protein concentrates (WPC) with high protein content can be used to substitute hydrocolloid stabilizers. In this study, the effect of the addition of WPC with 75% protein in place of a part of the nonfat milk powder on the physical properties of nonfat fermented milk drink with 6% dry matter was investigated. Use of an appropriate level of WPC was found to be important for obtaining a desirable effect on the physical properties of nonfat fermented milk drink. The effect of WPC was found to be comparable to those of commonly used hydrocolloid stabilizers. Use of WPC also enhances the nutritional value of the product as whey proteins have a high biological value. [source]

The effect of enamel matrix proteins and deproteinized bovine bone mineral on heterotopic bone formation

CLINICAL ORAL IMPLANTS RESEARCH, Issue 4 2006
Nikolaos Donos
Abstract Aim: To evaluate the osteoinductive potential of deproteinized bovine bone mineral (DBBM) and an enamel matrix derivative (EMD) in the muscle of rats. Material and methods: Sixteen rats were used in this study. The animals were divided in three groups. Group A: a pouch was created in one of the pectoralis profundis muscles of the thorax of the rats and DBBM particles (Bio-Oss®) were placed into the pouch. Healing: 60 days. Group B: a small pouch was created on both pectoralis profundis muscles at each side of the thorax midline. In one side, a mixture of EMD (Emdogain®) mixed with DBBM was placed into one of the pouches, whereas in the contralateral side of the thorax the pouch was implanted with DBBM mixed with the propylene glycol alginate (PGA , carrier for enamel matrix proteins of EMD). Healing: 60 days. Group C: the same procedure as group B, but with a healing period of 120 days. Qualitative histological analysis of the results was performed. Results: At 60 days, the histological appearance of the DBBM particles implanted alone was similar to that of the particles implanted together with EMD or PGA at both 60 and 120 days. The DBBM particles were encapsulated into a connective tissue stroma and an inflammatory infiltrate. At 120 days, the DBBM particles implanted together with EMD or PGA exhibited the presence of resorption lacunae in some cases. Intramuscular bone formation was not encountered in any group. Conclusion: The implantation of DBBM particles alone, combined with EMD or its carrier (PGA) failed to exhibit extraskeletal, bone-inductive properties. [source]